EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ONC201 exerts oncogenic effects beyond its mitochondria-disturbing role in neuroblastoma subsets

Jyun-Hong Jiang, Yu-Han Lin, Pei-Lin Liao, Ting-Ya Chen, Hui-Ching Chuang, Chao-Cheng Huang, Wen-Ming Hsu, Jiin-Haur Chuang, Wei-Shiung Lian

Journal of Molecular Medicine · 2025

DOI: 10.1007/s00109-025-02541-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Medicine, 2025. Verfasst von Jyun-Hong Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Kaohsiung Chang Gung Memorial Hospital, Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang …. Hauptthemen laut MEDLINE: Neuroblastoma, Mitochondria, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang Gung Memorial Hospital, Ministry of Health and Welfare, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroblastoma (NB) is a formidable challenge in pediatric oncology due to its intricate molecular landscape, necessitating multifaceted therapeutic approaches. ONC201 is an imipridone antibiotic compound with a promising drug candidate leveraging its potent anticancer properties against the mitochondrial proteases ClpP and ClpX. Despite demonstrating early clinical promise, particularly in MYCN -amplified NB, its efficacy in non- MYCN -amplified NB remains a subject worthy of investigation. In this study, we extended the coverage of ONC201 to treat non- MYCN -amplified NB, and our data implicated ONC201’s inability to reduce tumor growth in animal models harboring SK-N-AS or SK-N-FI cell lines. Interestingly, ONC201 induced the expression of oncogenic markers c-Myc and LGR5 while downregulating the tumor suppressor ATRX. While it fails to attenuate tumor neovascularization in non- MYCN -amplified NB xenografts, its effectiveness differs from that of its MYCN-amplified counterpart. Rho zero (ρ0)-SK-N-AS cells treated with ONC201 showed comparable observed trends in parental SK-N-AS cells, including LGR5 upregulation and ATRX downregulation, suggesting that ONC201’s multifaceted actions extend beyond mitochondrial targets. Our elucidation highlights the need to discern molecular signatures when deploying ONC201 monotherapy against NB, which lacks MYCN- amplification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaMitochondriaAntineoplastic AgentsHumansAnimalsMiceCell Line, TumorXenograft Model Antitumor AssaysN-Myc Proto-Oncogene ProteinReceptors, G-Protein-CoupledX-linked Nuclear ProteinGene Expression Regulation, NeoplasticCell Proliferation

Stichwörter der Autor:innen

ATRXLGR5NeuroblastomaNon-MYCN-amplified cell lineONC201

Substanzen

N-Myc Proto-Oncogene ProteinAntineoplastic AgentsReceptors, G-Protein-CoupledX-linked Nuclear ProteinATRX protein, human

Autor:innen und Institutionen

  • Department of Pediatric Surgery, Kaohsiung Chang Gung Memorial Hospital, Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Kaohsiung, Taiwan.
  • Center for Mitochondrial Research and Medicine, College of Medicine Chang Gung University, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
  • Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
  • Department of Pathology, Kaohsiung Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Kaohsiung, Taiwan.
  • Department of Surgery, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Department of Pediatric Surgery, Kaohsiung Chang Gung Memorial Hospital, Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Kaohsiung, Taiwan. jhchuang@cloud.cgmh.org.tw.

Förderung

  • Chang Gung Memorial Hospital
  • Ministry of Health and Welfare
  • National Science and Technology Council

Zitieren

APA

Jiang, J. H., Lin, Y. H., Liao, P. L., Chen, T. Y., Chuang, H. C., Huang, C. C., Hsu, W. M., Chuang, J. H., & Lian, W. S. (2025). ONC201 exerts oncogenic effects beyond its mitochondria-disturbing role in neuroblastoma subsets. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-025-02541-0

Vancouver

Jiang JH, Lin YH, Liao PL, Chen TY, Chuang HC, Huang CC, et al. ONC201 exerts oncogenic effects beyond its mitochondria-disturbing role in neuroblastoma subsets. Journal of Molecular Medicine. 2025. doi:10.1007/s00109-025-02541-0

BibTeX
@article{Jiang2025,
  author = {Jiang, Jyun-Hong and Lin, Yu-Han and Liao, Pei-Lin and Chen, Ting-Ya and Chuang, Hui-Ching and Huang, Chao-Cheng and Hsu, Wen-Ming and Chuang, Jiin-Haur and Lian, Wei-Shiung},
  title = {ONC201 exerts oncogenic effects beyond its mitochondria-disturbing role in neuroblastoma subsets},
  journal = {Journal of Molecular Medicine},
  year = {2025},
  doi = {10.1007/s00109-025-02541-0}
}
Kostenlos starten →